skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Frankfurt, Germany - Friday, 6 May, 2022 - The Global Generics and Biosimilars Awards have been established to recognise and reward the innovation, dedication and expertise shown by companies and individuals in global off-patent pharmaceuticals.

Now in its 9th year, the awards will focus on activity between 1 July 2021 and 31 July 2022, and include categories such as the prestigious Company of the Year global and regional awards, as well as Biosimilar and Value Added Medicine Initiatives of the Year, Acquisition of the Year, Leader of the Year, Regulatory Achievement of the Year and Industry Partner of the Year.

“We’re thrilled to be co-locating with CPhI Worldwide in Frankfurt, and showcasing the ‘best of the best’ in generics, biosimilars and value added medicines,” commented Dave Wallace, Executive Editor, Generics Bulletin. “The activities of the off-patent industry play a key part in driving value, choice and access for healthcare systems and for patients around the world. We’re honoured to be championing the companies and individuals leading this change for good.” 

The Global Generics and Biosimilars Awards prides itself on its independence, with winners chosen solely on merit and acknowledged as most deserving for their unique achievements. Applicants are welcomed from any research-based pharmaceutical or biotech company, operating anywhere around the world, including third-party and partner companies supplying services to the pharmaceutical industry.

Entries are now open and will close on Friday 19 August 2022. All submissions will be reviewed by an independent panel of judges, selected for their expertise and impartiality. The winners will be announced at a ceremony at the Frankfurt Marriott Hotel, Germany on Wednesday 2 November 2022.

For further details on the Awards, including Awards submission criteria, please visit:


About Informa Pharma Intelligence

Trusted by over 3,000 of the world’s leading pharmaceutical companies, CROs, medtech and biotech organizations, and healthcare service providers, the Pharma Intelligence suite of intelligence solutions delivers vital, accurate, and timely intelligence about the drug development pipeline, to pharmaceutical and biomedical decision makers around the world.

At Pharma Intelligence, global teams of subject area experts follow and analyse key diseases, clinical trials, drug approvals and R&D activities, as part of the breadth and depth of data available to customers.

For more information visit


About the Global Generics and Biosimilars Awards

The Global Generics and Biosimilars Awards is the one night of the year when the off-patent pharmaceutical industry’s greatest achievements are put in the spotlight.

Taking place on Wednesday 2 November 2022 at the Frankfurt Marriott Hotel, Germany, the Awards recognise companies across the off-patent industry, including small-molecule generics, biosimilars and value-added medicines, by celebrating their successes over the past year. 

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: